← All categories

Korea Stocks — 2 / 36

Korea Stocks, page 2 of 36 — 24 articles published 2026-09-20 ~ 2026-09-22.

Moonbae Steel (008420) Stock Outlook 2026: The Korean POSCO Distributor Trading Below Its Asset Value

Moonbae Steel (008420) Stock Outlook 2026: The Korean POSCO Distributor Trading Below Its Asset Value

Moonbae Steel (008420) stock outlook 2026 for international investors. We cover its role as one of POSCO's nationwide hot-rolled coil distributors (roughly a 9% share), the skelp-processing and steel-sheet resale business, a side real-estate leasing operation that cushions margins, Chinese oversupply and construction-cycle risk, and how a foreign investor should think about Korean dividend withholding, the large-shareholder capital gains threshold, and won FX exposure before buying this KOSPI small-cap.

Moonbae Steel 008420 Korea Stocks
Kukdong Oil & Chemical (014530) Stock Outlook 2026: A Feedstock Supplier Sitting on Undervalued Land

Kukdong Oil & Chemical (014530) Stock Outlook 2026: A Feedstock Supplier Sitting on Undervalued Land

Kukdong Oil & Chemical (KRX 014530) 2026 stock analysis: the lubricant, asphalt and petroleum-resin business behind a low-profile Korean small cap, why Hankook Tire bought into it, the hidden real-estate angle behind its low P/B rating, Korea's domestic share tax rules explained for foreign investors, and the metrics that actually matter each quarter.

Kukdong Oil Chemical 014530 Korea Stocks
Anguk Pharmaceutical (KRX: 001540) Stock Outlook 2026: A Cough-Syrup Cash Cow With a Family Governance Overhang

Anguk Pharmaceutical (KRX: 001540) Stock Outlook 2026: A Cough-Syrup Cash Cow With a Family Governance Overhang

Anguk Pharmaceutical (001540) stock outlook 2026 for foreign investors. A deep dive into its Sinectura respiratory-drug cash cow, incrementally modified drug and health-supplement expansion, family ownership governance risk, peer comparison against Korean small-cap pharma names, and how Korea's domestic securities transaction tax, dividend withholding tax, and major-shareholder capital gains rule actually apply to this KOSPI-listed stock.

Anguk Pharmaceutical 001540 Sinectura